Tara M. Cox, Ph.D. - Publications

Affiliations: 
2003 Duke University, Durham, NC 
Area:
Environmental Sciences, Fisheries and Aquaculture Agriculture

11/252 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Lewison RL, Crowder LB, Wallace BP, Moore JE, Cox T, Zydelis R, McDonald S, DiMatteo A, Dunn DC, Kot CY, Bjorkland R, Kelez S, Soykan C, Stewart KR, Sims M, et al. Global patterns of marine mammal, seabird, and sea turtle bycatch reveal taxa-specific and cumulative megafauna hotspots. Proceedings of the National Academy of Sciences of the United States of America. 111: 5271-6. PMID 24639512 DOI: 10.1073/Pnas.1318960111  0.533
2011 Lewison R, Soykan C, Cox T, Peckham H, Pilcher N, LeBoeuf N, McDonald S, Moore J, Safina C, Crowder L. Ingredients for Addressing the Challenges of Fisheries Bycatch Bulletin of Marine Science. 87: 235-250. DOI: 10.5343/Bms.2010.1062  0.314
2010 Moore JE, Cox TM, Lewison RL, Read AJ, Bjorkland R, McDonald SL, Crowder LB, Aruna E, Ayissi I, Espeut P, Joynson-Hicks C, Pilcher N, Poonian CNS, Solarin B, Kiszka J. An interview-based approach to assess marine mammal and sea turtle captures in artisanal fisheries Biological Conservation. 143: 795-805. DOI: 10.1016/J.Biocon.2009.12.023  0.531
2009 Poonian C, Hauzer M, Allaoui A, Cox T, Moore J, Read A, Lewison R, Crowder L. Rapid Assessment of Sea Turtle and Marine Mammal Bycatch in the Union of the Comoros Western Indian Ocean Journal of Marine Science. 7. DOI: 10.4314/Wiojms.V7I2.48279  0.542
2009 Moore JE, Wallace BP, Lewison RL, Žydelis R, Cox TM, Crowder LB. A review of marine mammal, sea turtle and seabird bycatch in USA fisheries and the role of policy in shaping management Marine Policy. 33: 435-451. DOI: 10.1016/J.Marpol.2008.09.003  0.315
2007 Cox TM, Lewison RL, Žydelis R, Crowder LB, Safina C, Read AJ. Comparing effectiveness of experimental and implemented bycatch reduction measures: The ideal and the real Conservation Biology. 21: 1155-1164. PMID 17883481 DOI: 10.1111/J.1523-1739.2007.00772.X  0.518
2006 Smith RJ, Cox TM, Westgate AJ. Movements of harbor seals (Phoca vitulina mellonae) in Lacs des Loups Marins, Quebec Marine Mammal Science. 22: 480-485. DOI: 10.1111/J.1748-7692.2006.00024.X  0.58
2004 Cox TM, Read AJ. Echolocation behavior of harbor porpoises Phocoena phocoena around chemically enhanced gill nets Marine Ecology Progress Series. 279: 275-282. DOI: 10.3354/Meps279275  0.493
2004 Cox TM, Read AJ, Swanner D, Urian K, Waples D. Behavioral responses of bottlenose dolphins, Tursiops truncatus, to gillnets and acoustic alarms Biological Conservation. 115: 203-212. DOI: 10.1016/S0006-3207(03)00108-3  0.499
1998 Westgate AJ, Read AJ, Cox TM, Schofield TD, Whitaker BR, Anderson KE. MONITORING A REHABILITATED HARBOR PORPOISE USING SATELLITE TELEMETRY Marine Mammal Science. 14: 599-604. DOI: 10.1111/J.1748-7692.1998.Tb00746.X  0.649
1998 Westgate AJ, Read AJ, Cox TM, Schofield TD, Whitaker BR, Anderson KE. Monitoring a rehabilitated harbor porpoise using satellite telemetry Marine Mammal Science. 14: 599-604.  0.649
Low-probability matches (unlikely to be authored by this person)
2008 Sims M, Cox T, Lewison R. Modeling spatial patterns in fisheries bycatch: improving bycatch maps to aid fisheries management. Ecological Applications : a Publication of the Ecological Society of America. 18: 649-61. PMID 18488624 DOI: 10.1890/07-0685.1  0.294
2016 Thompson J, Curran MC, Cox T. “Capture” Me if You Can: Estimating abundance of dolphin populations Science Activities: Classroom Projects and Curriculum Ideas. 53: 49-67. DOI: 10.1080/00368121.2015.1135863  0.277
2016 Perrtree RM, Sayigh LS, Williford A, Bocconcelli A, Curran MC, Cox TM. First observed wild birth and acoustic record of a possible infanticide attempt on a common bottlenose dolphin (Tursiops truncatus) Marine Mammal Science. 32: 376-385. DOI: 10.1111/Mms.12248  0.265
2014 Perrtree RM, Kovacs CJ, Cox TM. Standardization and application of metrics to quantify human-interaction behaviors by the bottlenose dolphin (Tursiops spp.) Marine Mammal Science. 30: 1320-1334. DOI: 10.1111/Mms.12114  0.24
2011 Bowen-Stevens SR, Cox TM, Curran MC. What are bottlenose dolphins doing on land? An activity teaching the scientific method through the unique behavior of strand feeding American Biology Teacher. 73: 407-411. DOI: 10.1525/Abt.2011.73.7.7  0.224
2017 Kovacs CJ, Perrtree RM, Cox TM. Social Differentiation in Common Bottlenose Dolphins (Tursiops truncatus) that Engage in Human-Related Foraging Behaviors. Plos One. 12: e0170151. PMID 28146563 DOI: 10.1371/Journal.Pone.0170151  0.214
2008 Cox TM, Aerts JM, Belmatoug N, Cappellini MD, vom Dahl S, Goldblatt J, Grabowski GA, Hollak CE, Hwu P, Maas M, Martins AM, Mistry PK, Pastores GM, Tylki-Szymanska A, Yee J, et al. Management of non-neuronopathic Gaucher disease with special reference to pregnancy, splenectomy, bisphosphonate therapy, use of biomarkers and bone disease monitoring. Journal of Inherited Metabolic Disease. 31: 319-36. PMID 18509745 DOI: 10.1007/S10545-008-0779-Z  0.122
2005 Beck M, Cox TM, Mehta A, Widmer U. Foreword Acta Paediatrica, International Journal of Paediatrics, Supplement. 94: 5-6. DOI: 10.1080/08035320510028003  0.12
1990 Cox TM. Haemochromatosis Blood Reviews. 4: 75-87. PMID 2194598 DOI: 10.1016/0268-960X(90)90030-V  0.12
2012 Pavlova EV, Deegan PB, Cox TM. Biomarkers for osteonecrosis in Gaucher disease. Expert Opinion On Medical Diagnostics. 6: 1-13. PMID 23480616 DOI: 10.1517/17530059.2012.626402  0.116
2014 te Vruchte D, Speak AO, Wallom KL, Al Eisa N, Smith DA, Hendriksz CJ, Simmons L, Lachmann RH, Cousins A, Hartung R, Mengel E, Runz H, Beck M, Amraoui Y, Imrie J, ... ... Cox TM, et al. Relative acidic compartment volume as a lysosomal storage disorder-associated biomarker. The Journal of Clinical Investigation. 124: 1320-8. PMID 24487591 DOI: 10.1172/Jci72835  0.111
2010 Hollak CE, vom Dahl S, Aerts JM, Belmatoug N, Bembi B, Cohen Y, Collin-Histed T, Deegan P, van Dussen L, Giraldo P, Mengel E, Michelakakis H, Manuel J, Hrebicek M, Parini R, ... ... Cox TM, et al. Force majeure: therapeutic measures in response to restricted supply of imiglucerase (Cerezyme) for patients with Gaucher disease. Blood Cells, Molecules & Diseases. 44: 41-7. PMID 19804996 DOI: 10.1016/J.Bcmd.2009.09.006  0.108
2015 Shemesh E, Deroma L, Bembi B, Deegan P, Hollak C, Weinreb NJ, Cox TM. Enzyme replacement and substrate reduction therapy for Gaucher disease. The Cochrane Database of Systematic Reviews. 3: CD010324. PMID 25812601 DOI: 10.1002/14651858.Cd010324.Pub2  0.103
2016 Hazelkorn RA, Schulte BA, Cox TM. Persistent Effects of Begging on Common Bottlenose Dolphin (Tursiops truncatus) Behavior in an Estuarine Population Aquatic Mammals. 42: 531-541. DOI: 10.1578/AM.42.4.2016.531  0.099
2015 Vitner EB, Vardi A, Cox TM, Futerman AH. Emerging therapeutic targets for Gaucher disease. Expert Opinion On Therapeutic Targets. 19: 321-34. PMID 25416676 DOI: 10.1517/14728222.2014.981530  0.096
2004 Elstein D, Hollak C, Aerts JM, van Weely S, Maas M, Cox TM, Lachmann RH, Hrebicek M, Platt FM, Butters TD, Dwek RA, Zimran A. Sustained therapeutic effects of oral miglustat (Zavesca, N-butyldeoxynojirimycin, OGT 918) in type I Gaucher disease. Journal of Inherited Metabolic Disease. 27: 757-66. PMID 15505381 DOI: 10.1023/B:Boli.0000045756.54006.17  0.096
2011 Deegan PB, Pavlova E, Tindall J, Stein PE, Bearcroft P, Mehta A, Hughes D, Wraith JE, Cox TM. Osseous manifestations of adult gaucher disease in the era of enzyme replacement therapy Medicine. 90: 52-60. PMID 21200186 DOI: 10.1097/Md.0B013E3182057Be4  0.095
2004 Pastores GM, Weinreb NJ, Aerts H, Andria G, Cox TM, Giralt M, Grabowski GA, Mistry PK, Tylki-Szyma?ska A. Therapeutic goals in the treatment of Gaucher disease. Seminars in Hematology. 41: 4-14. PMID 15468045 DOI: 10.1053/J.Seminhematol.2004.07.009  0.094
2005 Whitfield PD, Calvin J, Hogg S, O'Driscoll E, Halsall D, Burling K, Maguire G, Wright N, Cox TM, Meikle PJ, Deegan PB. Monitoring enzyme replacement therapy in Fabry disease - Role of urine globotriaosylceramide Journal of Inherited Metabolic Disease. 28: 21-33. PMID 15702403 DOI: 10.1007/S10545-005-4415-X  0.094
2010 Weinreb NJ, Cappellini MD, Cox TM, Giannini EH, Grabowski GA, Hwu WL, Mankin H, Martins AM, Sawyer C, vom Dahl S, Yeh MS, Zimran A. A validated disease severity scoring system for adults with type 1 Gaucher disease. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 12: 44-51. PMID 20027115 DOI: 10.1097/Gim.0B013E3181C39194  0.092
2014 Cachón-González MB, Wang SZ, Ziegler R, Cheng SH, Cox TM. Reversibility of neuropathology in Tay-Sachs-related diseases. Human Molecular Genetics. 23: 730-48. PMID 24057669 DOI: 10.1093/Hmg/Ddt459  0.09
2014 Vitner EB, Salomon R, Farfel-Becker T, Meshcheriakova A, Ali M, Klein AD, Platt FM, Cox TM, Futerman AH. RIPK3 as a potential therapeutic target for Gaucher's disease Nature Medicine. 20: 204-208. PMID 24441827 DOI: 10.1038/Nm.3449  0.089
1990 Cox TM. Hereditary fructose intolerance Bailliere's Clinical Gastroenterology. 4: 61-78. PMID 2207353 DOI: 10.1016/0950-3528(90)90039-J  0.088
1999 Rellos P, Ali M, Vidailhet M, Sygusch J, Cox TM. Alteration of substrate specificity by a naturally-occurring aldolase B mutation (Ala337→Val) in fructose intolerance Biochemical Journal. 340: 321-327. PMID 10229688 DOI: 10.1042/Bj3400321  0.088
2003 Dwek RA, Butters TD, Platt FM, Cox TM. Introduction Philosophical Transactions of the Royal Society B: Biological Sciences. 358: 845-846. DOI: 10.1098/rstb.2003.1281  0.087
2005 Deegan PB, Moran MT, McFarlane I, Schofield JP, Boot RG, Aerts JM, Cox TM. Clinical evaluation of chemokine and enzymatic biomarkers of Gaucher disease. Blood Cells, Molecules & Diseases. 35: 259-67. PMID 16125420 DOI: 10.1016/J.Bcmd.2005.05.005  0.087
2004 Boot RG, Verhoek M, de Fost M, Hollak CE, Maas M, Bleijlevens B, van Breemen MJ, van Meurs M, Boven LA, Laman JD, Moran MT, Cox TM, Aerts JM. Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention. Blood. 103: 33-9. PMID 12969956 DOI: 10.1182/Blood-2003-05-1612  0.087
2005 Cox TM. Biomarkers in lysosomal storage diseases: a review. Acta Paediatrica (Oslo, Norway : 1992). Supplement. 94: 39-42; discussion 37. PMID 15895710 DOI: 10.1111/J.1651-2227.2005.Tb02109.X  0.084
2001 Cox TM. Gaucher disease: understanding the molecular pathogenesis of sphingolipidoses. Journal of Inherited Metabolic Disease. 24: 106-21; discussion 8. PMID 11758671 DOI: 10.1023/A:1012496514170  0.083
2010 Cox TM. Gaucher disease: clinical profile and therapeutic developments. Biologics : Targets & Therapy. 4: 299-313. PMID 21209725 DOI: 10.2147/Btt.S7582  0.082
1992 Mistry PK, Smith SJ, Ali M, Cox TM, Hatton CSR, McIntyre N. Genetic diagnosis of Gaucher's disease The Lancet. 339: 889-892. PMID 1348297 DOI: 10.1016/0140-6736(92)90928-V  0.082
2015 Cox TM. Innovative treatments for lysosomal diseases. Best Practice & Research. Clinical Endocrinology & Metabolism. 29: 275-311. PMID 25987179 DOI: 10.1016/J.Beem.2015.01.001  0.082
2003 Cox TM. Future perspectives for glycolipid research in medicine. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 358: 967-73. PMID 12803931 DOI: 10.1098/Rstb.2003.1270  0.081
2011 Deane JE, Graham SC, Kim NN, Stein PE, McNair R, Cachón-González MB, Cox TM, Reada RJ. Insights into Krabbe disease from structures of galactocerebrosidase Proceedings of the National Academy of Sciences of the United States of America. 108: 15169-15173. PMID 21876145 DOI: 10.1073/Pnas.1105639108  0.079
2003 Cox TM, Aerts JM, Andria G, Beck M, Belmatoug N, Bembi B, Chertkoff R, Vom Dahl S, Elstein D, Erikson A, Giralt M, Heitner R, Hollak C, Hrebicek M, Lewis S, et al. The role of the iminosugar N-butyldeoxynojirimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease: a position statement. Journal of Inherited Metabolic Disease. 26: 513-26. PMID 14605497 DOI: 10.1023/A:1025902113005  0.078
2014 Hyry HI, Stern AD, Cox TM, Roos JCP. Commentary: Limits on use of health economic assessments for rare diseases Qjm. 107: 241-245. PMID 24453281 DOI: 10.1093/Qjmed/Hcu016  0.078
2005 Deegan PB, Cox TM. Clinical evaluation of biomarkers in Gaucher disease. Acta Paediatrica (Oslo, Norway : 1992). Supplement. 94: 47-50; discussion 37. PMID 15895712 DOI: 10.1111/J.1651-2227.2005.Tb02111.X  0.078
1998 Cox TM, Kelly AL. Haemochromatosis: An inherited metal and toxicity syndrome Current Opinion in Genetics and Development. 8: 274-281. PMID 9691000 DOI: 10.1016/S0959-437X(98)80081-6  0.078
2012 Stein PE, Badminton MN, Barth JH, Rees DC, Sarkany R, Stewart MF, Cox TM. Acute intermittent porphyria: fatal complications of treatment. Clinical Medicine (London, England). 12: 293-4. PMID 22783787 DOI: 10.7861/Clinmedicine.12-3-293  0.078
2015 Hyry HI, Roos JC, Cox TM. Orphan drugs: expensive yet necessary. Qjm : Monthly Journal of the Association of Physicians. PMID 26337658 DOI: 10.1093/Qjmed/Hcv150  0.077
2015 Hyry HI, Roos JC, Cox TM. Orphan drugs: expensive yet necessary. Qjm : Monthly Journal of the Association of Physicians. 108: 269-72. PMID 25434052 DOI: 10.1093/qjmed/hcu240  0.077
2012 Smith NJ, Winstone AM, Stellitano L, Cox TM, Verity CM. GM2 gangliosidosis in a UK study of children with progressive neurodegeneration: 73 cases reviewed Developmental Medicine and Child Neurology. 54: 176-182. PMID 22115551 DOI: 10.1111/J.1469-8749.2011.04160.X  0.077
1999 Schofield JP, Cox TM, Caskey CT, Wakamiya M. Mice deficient in the urea-cycle enzyme, carbamoyl phosphate synthetase I, die during the early neonatal period from hyperammonemia. Hepatology (Baltimore, Md.). 29: 181-5. PMID 9862865 DOI: 10.1002/Hep.510290112  0.077
2005 Cox TM. Substrate reduction therapy for lysosomal storage diseases. Acta Paediatrica (Oslo, Norway : 1992). Supplement. 94: 69-75; discussion 57. PMID 15895716 DOI: 10.1111/J.1651-2227.2005.Tb02116.X  0.076
2012 Deegan PB, Cox TM. Imiglucerase in the treatment of Gaucher disease: A history and perspective Drug Design, Development and Therapy. 6: 81-106. PMID 22563238  0.076
1988 Cross NCP, Tolan DR, Cox TM. Catalytic deficiency of human aldolase B in hereditary fructose intolerance caused by a common missense mutation Cell. 53: 881-885. PMID 3383242 DOI: 10.1016/S0092-8674(88)90349-2  0.076
2008 Wang SZ, Cachón-González MB, Stein PE, Lachmann RH, Corry PC, Wraith JE, Cox TM. A novel HEXB mutation and its structural effects in juvenile Sandhoff disease Molecular Genetics and Metabolism. 95: 236-238. PMID 18930675 DOI: 10.1016/J.Ymgme.2008.08.007  0.075
1997 Rhodes DA, Raha-Chowdhury R, Cox TM, Trowsdale J. Homozygosity for the predominant Cys282Tyr mutation and absence of disease expression in hereditary haemochromatosis. Journal of Medical Genetics. 34: 761-4. PMID 9321765  0.074
1993 Reardon DM, Seymour CA, Cox TM, Pinder JC, Schofield AE, Tanner MJA. Hereditary ovalocytosis with compensated haemolysis British Journal of Haematology. 85: 197-199. PMID 8251392  0.073
2010 Cox TM. Eliglustat tartrate, an orally active glucocerebroside synthase inhibitor for the potential treatment of Gaucher disease and other lysosomal storage diseases Current Opinion in Investigational Drugs. 11: 1169-1181. PMID 20872320  0.073
2015 Hyry HI, Manuel J, Cox TM, Roos JC. Compassionate use of orphan drugs. Orphanet Journal of Rare Diseases. 10: 100. PMID 26292942 DOI: 10.1186/S13023-015-0306-X  0.073
2005 Cox TM, Jack N, Lofthouse S, Watling J, Haines J, Warren MJ. King George III and porphyria: an elemental hypothesis and investigation. Lancet (London, England). 366: 332-5. PMID 16039338 DOI: 10.1016/S0140-6736(05)66991-7  0.073
1999 Halsall DJ, Halligan EP, Elsey TS, Cox TM. Metachromatic leucodystrophy: a newly identified mutation in arylsulphatase A, D281Y, found as a compound heterozygote with I179L in an adult onset case Human Mutation. 14: 447. PMID 10533072 DOI: 10.1002/(Sici)1098-1004(199911)14:5<447::Aid-Humu12>3.0.Co;2-1  0.072
1999 Cox TM. Mendel and his legacy Qjm - Monthly Journal of the Association of Physicians. 92: 183-186. PMID 10396604 DOI: 10.1093/Qjmed/92.4.183  0.072
2016 Eichler FS, Cox TM, Crombez E, Dali CÍ, Kohlschütter A. Metachromatic Leukodystrophy: An Assessment of Disease Burden. Journal of Child Neurology. PMID 27389394 DOI: 10.1177/0883073816656401  0.072
2004 Lanzara C, Roetto A, Daraio F, Rivard S, Ficarella R, Simard H, Cox TM, Cazzola M, Piperno A, Gimenez-Roqueplo AP, Grammatico P, Volinia S, Gasparini P, Camaschella C. Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis. Blood. 103: 4317-21. PMID 14982873 DOI: 10.1182/Blood-2004-01-0192  0.07
1994 Ali M, Tunçman G, Cross NCP, Vidailhet M, Bökesoy I, Gitzelmann R, Cox TM. Null alleles of the aldolase B gene in patients with hereditary fructose intolerance Journal of Medical Genetics. 31: 499-503. PMID 8071980 DOI: 10.1136/Jmg.31.6.499  0.07
1994 Cox TM. Aldolase B and fructose intolerance Faseb Journal. 8: 62-71. PMID 8299892 DOI: 10.1096/Fasebj.8.1.8299892  0.07
2002 De Gobbi M, Roetto A, Piperno A, Mariani R, Alberti F, Papanikolaou G, Politou M, Lockitch G, Girelli D, Fargion S, Cox TM, Gasparini P, Cazzola M, Camaschella C. Natural history of juvenile haemochromatosis. British Journal of Haematology. 117: 973-9. PMID 12060140 DOI: 10.1046/j.1365-2141.2002.03509.x  0.07
2012 van Dussen L, Cox TM, Hendriks EJ, Morris E, Akkerman EM, Maas M, Groener JE, Aerts JM, Deegan PB, Hollak CE. Effects of switching from a reduced dose imiglucerase to velaglucerase in type 1 Gaucher disease: clinical and biochemical outcomes. Haematologica. 97: 1850-4. PMID 22773601 DOI: 10.3324/Haematol.2011.059071  0.069
2013 Bradbury AM, Cochran JN, McCurdy VJ, Johnson AK, Brunson BL, Gray-Edwards H, Leroy SG, Hwang M, Randle AN, Jackson LS, Morrison NE, Baek RC, Seyfried TN, Cheng SH, Cox NR, ... ... Cox TM, et al. Therapeutic response in feline sandhoff disease despite immunity to intracranial gene therapy. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 1306-15. PMID 23689599 DOI: 10.1038/Mt.2013.86  0.068
1996 Mistry PK, Wraight EP, Cox TM. Therapeutic delivery of proteins to macrophages: Implications for treatment of Gaucher's disease Lancet. 348: 1555-1559. PMID 8950883 DOI: 10.1016/S0140-6736(96)04451-0  0.068
2012 Cox TM, Amato D, Hollak CE, Luzy C, Silkey M, Giorgino R, Steiner RD. Evaluation of miglustat as maintenance therapy after enzyme therapy in adults with stable type 1 Gaucher disease: a prospective, open-label non-inferiority study. Orphanet Journal of Rare Diseases. 7: 102. PMID 23270487 DOI: 10.1186/1750-1172-7-102  0.068
1990 Cross NCP, Cox TM. Partial aldolase B gene deletions in hereditary fructose intolerance American Journal of Human Genetics. 47: 101-106. PMID 2349937  0.068
2015 Cox TM, Drelichman G, Cravo R, Balwani M, Burrow TA, Martins AM, Lukina E, Rosenbloom B, Ross L, Angell J, Puga AC. Eliglustat compared with imiglucerase in patients with Gaucher's disease type 1 stabilised on enzyme replacement therapy: a phase 3, randomised, open-label, non-inferiority trial. Lancet (London, England). 385: 2355-62. PMID 25819691 DOI: 10.1016/S0140-6736(14)61841-9  0.068
2015 Cox TM, Rosenbloom BE, Barker RA. Gaucher disease and comorbidities: B-cell malignancy and parkinsonism. American Journal of Hematology. 90: S25-8. PMID 26096744 DOI: 10.1002/Ajh.24057  0.067
1996 James CL, Rellos P, Ali M, Heeley AF, Cox TM. Neonatal screening for hereditary fructose intolerance: Frequency of the most common mutant aldolase E allele (A149P) in the British population Journal of Medical Genetics. 33: 837-841. PMID 8933337 DOI: 10.1136/Jmg.33.10.837  0.067
2001 Cox TM. Gaucher's disease - An exemplary monogenic disorder Qjm - Monthly Journal of the Association of Physicians. 94: 399-402. PMID 11493715 DOI: 10.1093/Qjmed/94.8.399  0.066
2020 Plaza M, Burke T, Cox T, Flynn-Carroll A, Girndt A, Halford G, Martin DA, Sanchez-Fortún M, Sánchez-Tójar A, Somerville J, Schroeder J. Repeatable social network node-based metrics across populations and contexts in a passerine. Journal of Evolutionary Biology. PMID 32935411 DOI: 10.1111/Jeb.13703  0.066
2012 Cox TM, Cachón-González MB. The cellular pathology of lysosomal diseases Journal of Pathology. 226: 241-254. PMID 21990005 DOI: 10.1002/Path.3021  0.066
2001 Hayman AR, Macary P, Lehner PJ, Cox TM. Tartrate-resistant acid phosphatase (Acp 5): Identification in diverse human tissues and dendritic cells Journal of Histochemistry and Cytochemistry. 49: 675-683. PMID 11373314 DOI: 10.1177/002215540104900601  0.066
2004 Roetto A, Daraio F, Porporato P, Caruso R, Cox TM, Cazzola M, Gasparini P, Piperno A, Camaschella C. Screening hepcidin for mutations in juvenile hemochromatosis: identification of a new mutation (C70R). Blood. 103: 2407-9. PMID 14630809 DOI: 10.1182/Blood-2003-10-3390  0.066
1993 Andrade ZA, Cox TM, Cheever AM. Regression of hepatic lesions after treatment of Schistosoma mansoni or Schistosoma japonicum infection in mice: A comparative study American Journal of Tropical Medicine and Hygiene. 49: 1-9. PMID 8352381  0.066
1988 Nunn AVW, Norris P, Hawk JLM, Cox TM. Zinc chelatase in human lymphocytes: Detection of the enzymatic defect in erythropoietic protoporphyria Analytical Biochemistry. 174: 146-150. PMID 3218729 DOI: 10.1016/0003-2697(88)90529-5  0.065
2006 Cachón-González MB, Wang SZ, Lynch A, Ziegler R, Cheng SH, Cox TM. Effective gene therapy in an authentic model of Tay-Sachs-related diseases. Proceedings of the National Academy of Sciences of the United States of America. 103: 10373-8. PMID 16801539 DOI: 10.1073/Pnas.0603765103  0.065
1997 Cox TM, Schofield JP. Gaucher's disease: Clinical features and natural history Bailliere's Clinical Haematology. 10: 657-689. PMID 9497857 DOI: 10.1016/S0950-3536(97)80033-9  0.065
2000 Moran MT, Schofield JP, Hayman AR, Shi GP, Young E, Cox TM. Pathologic gene expression in Gaucher disease: Up-regulation of cysteine proteinases including osteoclastic cathepsin K Blood. 96: 1969-1978. PMID 10961902 DOI: 10.1182/Blood.V96.5.1969.H8001969_1969_1978  0.065
2010 Griffiths WJH, Mayr R, McFarlane I, Hermann M, Halsall DJ, Zoller H, Cox TM. Clinical presentation and molecular pathophysiology of autosomal dominant hemochromatosis caused by a novel ferroportin mutation Hepatology. 51: 788-795. PMID 19937651 DOI: 10.1002/Hep.23377  0.065
1983 Cox TM, O'Donnell MW, Camilleri M. Allelic heterogeneity in adult hereditary fructose intolerance. Detection of structural mutations in the aldolase B molecule Molecular Biology &Amp; Medicine. 1: 393-400. PMID 6680153  0.065
1994 Cox TM. Therapeutic advances in Gaucher's disease: A model for the treatment of lysosomal storage diseases Forum - Trends in Experimental and Clinical Medicine. 4: 144-157.  0.065
2011 Roos JC, Lachmann RH, Carpenter RH, Cox TM. Latency vs saccadic parameters in lysosomal trials. Ophthalmology. 118: 794-794.e1. PMID 21459233 DOI: 10.1016/J.Ophtha.2010.10.022  0.064
2000 Hayman AR, Bune AJ, Bradley JR, Rashbass J, Cox TM. Osteoclastic tartrate-resistant acid phosphatase (Acp 5): Its localization to dendritic cells and diverse murine tissues Journal of Histochemistry and Cytochemistry. 48: 219-227. PMID 10639488 DOI: 10.1177/002215540004800207  0.064
2005 Zoller H, Cox TM. Hemochromatosis: genetic testing and clinical practice. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 3: 945-58. PMID 16234038 DOI: 10.1016/S1542-3565(05)00607-5  0.063
1994 Whitcombe DM, Albertson DG, Cox TM. Molecular Analysis of Functional and Nonfunctional Genes for Human Ferrochelatase: Isolation and Characterization of a FECH Pseudogene and Its Sublocalization on Chromosome 3 Genomics. 20: 482-486. PMID 8034322 DOI: 10.1006/geno.1994.1204  0.063
2013 Pavlova EV, Wang SZ, Archer J, Dekker N, Aerts JMFG, Karlsson S, Cox TM. B cell lymphoma and myeloma in murine Gaucher's disease Journal of Pathology. 231: 88-97. PMID 23775597 DOI: 10.1002/Path.4227  0.063
2012 Carter A, Rajan PS, Deegan P, Cox TM, Bearcroft P. Quantifying the Erlenmeyer flask deformity. The British Journal of Radiology. 85: 905-9. PMID 22010032 DOI: 10.1259/bjr/33890893  0.063
1982 Cox TM, Camilleri M, O'Donnell MW, Chadwick VS. Pseudodominant transmission of fructose intolerance in an adult and three offspring. Heterozygote detection by intestinal biopsy New England Journal of Medicine. 307: 537-540. PMID 7099225 DOI: 10.1056/NEJM198208263070906  0.063
2000 Rellos P, Sygusch J, Cox TM. Expression, purification, and characterization of natural mutants of human aldolase B. Role of quaternary structure in catalysis Journal of Biological Chemistry. 275: 1145-1151. PMID 10625657 DOI: 10.1074/Jbc.275.2.1145  0.063
2011 Cox TM. Alkaptonuria: Treasure your exceptions Journal of Inherited Metabolic Disease. 34: 1113-1114. PMID 21938512 DOI: 10.1007/S10545-011-9385-6  0.062
1990 Lord DK, Dunham I, Campbell RD, Bomford A, Strachan T, Cox TM. Molecular analysis of the human MHC class I region in hereditary haemochromatosis - A study by pulsed-field gel electrophoresis Human Genetics. 85: 531-536. PMID 2227939 DOI: 10.1007/Bf00194232  0.062
1995 Cox TM. Therapeutic use of fructose: Professional freedom, ‘pharmacovigilance’ and Europe Qjm. 88: 225-227. PMID 7796072 DOI: 10.1093/Oxfordjournals.Qjmed.A069052  0.061
2004 Hayman AR, Cox TM. Tartrate-resistant acid phosphatase: a potential target for therapeutic gold. Cell Biochemistry and Function. 22: 275-80. PMID 15338465 DOI: 10.1002/Cbf.1133  0.061
1994 Hayman AR, Cox TM. Purple acid phosphatase of the human macrophage and osteoclast: Characterization, molecular properties, and crystallization of the recombinant di-iron-oxo protein secreted by baculovirus-infected insect cells Journal of Biological Chemistry. 269: 1294-1300. PMID 8288593  0.061
1997 King TS, Anderson JR, Wraight EP, Hunter JO, Cox TM. Skeletal muscle weakness and dysphagia caused by acid maltase deficiency: Nutritional consequences of coincident celiac sprue Journal of Parenteral and Enteral Nutrition. 21: 46-49. PMID 9002085 DOI: 10.1177/014860719702100146  0.061
2015 Marsden JT, Guppy S, Stein P, Cox TM, Badminton M, Gardiner T, Barth JH, Stewart MF, Rees DC. Audit of the Use of Regular Haem Arginate Infusions in Patients with Acute Porphyria to Prevent Recurrent Symptoms. Jimd Reports. 22: 57-65. PMID 25762493 DOI: 10.1007/8904_2015_411  0.061
1993 Cox TM, Ali M, Rosien U. Dna diagnosis of fatal fructose intolerance from archival tissue Qjm. 86: 25-30. PMID 8438046 DOI: 10.1093/oxfordjournals.qjmed.a068733  0.06
2010 Champion H, Ramaswami U, Imrie J, Lachmann RH, Gallagher J, Cox TM, Wraith JE. Dietary modifications in patients receiving miglustat Journal of Inherited Metabolic Disease. 33: S379-S383. PMID 20844964 DOI: 10.1007/S10545-010-9193-4  0.06
2004 Lachmann RH, Grant IR, Halsall D, Cox TM. Twin pairs showing discordance of phenotype in adult Gaucher's disease. Qjm : Monthly Journal of the Association of Physicians. 97: 199-204. PMID 15028849 DOI: 10.1093/Qjmed/Hch036  0.06
2000 Cox TM, Mason B. Interest groups and the development of tripartism in east central Europe European Journal of Industrial Relations. 6: 325-347.  0.06
2003 Griffiths WJ, Cox TM. Co-localization of the mammalian hemochromatosis gene product (HFE) and a newly identified transferrin receptor (TfR2) in intestinal tissue and cells. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 51: 613-24. PMID 12704209 DOI: 10.1177/002215540305100507  0.059
1997 Cox TM. Erythropoietic protoporphyria Journal of Inherited Metabolic Disease. 20: 258-269. PMID 9211198 DOI: 10.1023/A:1005317124985  0.058
2012 Marchesan D, Cox TM, Deegan PB. Lysosomal delivery of therapeutic enzymes in cell models of Fabry disease Journal of Inherited Metabolic Disease. 35: 1107-1117. PMID 22450713 DOI: 10.1007/S10545-012-9472-3  0.058
1995 Ali M, Cox TM. Diverse mutations in the aldolase B gene that underlie the prevalence of hereditary fructose intolerance [2] American Journal of Human Genetics. 56: 1002-1005. PMID 7717389  0.058
2014 Praschberger R, Schranz M, Griffiths WJ, Baumgartner N, Hermann M, Lomas DJ, Pietrangelo A, Cox TM, Vogel W, Zoller H. Impact of D181V and A69T on the function of ferroportin as an iron export pump and hepcidin receptor. Biochimica Et Biophysica Acta. 1842: 1406-12. PMID 24859227 DOI: 10.1016/J.Bbadis.2014.05.011  0.058
2000 Hayman AR, Bune AJ, Cox TM. Widespread expression of tartrate-resistant acid phosphatase (Acp 5) in the mouse embryo Journal of Anatomy. 196: 433-441. PMID 10853965 DOI: 10.1046/J.1469-7580.2000.19630433.X  0.058
2013 Duran R, Mencacci NE, Angeli AV, Shoai M, Deas E, Houlden H, Mehta A, Hughes D, Cox TM, Deegan P, Schapira AH, Lees AJ, Limousin P, Jarman PR, Bhatia KP, et al. The glucocerobrosidase E326K variant predisposes to Parkinson's disease, but does not cause Gaucher's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 232-6. PMID 23225227 DOI: 10.1002/Mds.25248  0.057
2005 Zoller H, McFarlane I, Theurl I, Stadlmann S, Nemeth E, Oxley D, Ganz T, Halsall DJ, Cox TM, Vogel W. Primary iron overload with inappropriate hepcidin expression in V162del ferroportin disease. Hepatology (Baltimore, Md.). 42: 466-72. PMID 15986403 DOI: 10.1002/Hep.20775  0.056
1990 Norris PG, Nunn AV, Hawk JLM, Cox TM. Genetic heterogeneity in erythropoietic protoporphyria: A study of the enzymatic defect in nine affected families Journal of Investigative Dermatology. 95: 260-263. PMID 2384686  0.056
2015 Pavlova EV, Archer J, Wang S, Dekker N, Aerts JM, Karlsson S, Cox TM. Inhibition of UDP-glucosylceramide synthase in mice prevents Gaucher disease-associated B-cell malignancy. The Journal of Pathology. 235: 113-24. PMID 25256118 DOI: 10.1002/Path.4452  0.056
2012 Sargeant TJ, Drage DJ, Wang S, Apostolakis AA, Cox TM, Cachón-González MB. Characterization of Inducible Models of Tay-Sachs and Related Disease Plos Genetics. 8. PMID 23028353 DOI: 10.1371/Journal.Pgen.1002943  0.056
1994 Sarkany RPE, Whitcombe DM, Cox TM. Molecular characterization of a ferrochelatase gene defect causing anomalous RNA splicing in erythropoietic protoporphyria Journal of Investigative Dermatology. 102: 481-484. PMID 8151124 DOI: 10.1111/1523-1747.Ep12373073  0.055
1995 Cox TM, Whittington R, Goa K. Cost-effectiveness controversy [1] Pharmacoeconomics. 8: 82-83. PMID 10155604 DOI: 10.2165/00019053-199508010-00009  0.055
1995 Cox TM. Cost-Effectiveness Controversy Pharmacoeconomics. 8: 82-82. DOI: 10.2165/00019053-199508010-00009  0.055
2006 Perez-Amodio S, Jansen DC, Schoenmaker T, Vogels IM, Reinheckel T, Hayman AR, Cox TM, Saftig P, Beertsen W, Everts V. Calvarial osteoclasts express a higher level of tartrate-resistant acid phosphatase than long bone osteoclasts and activation does not depend on cathepsin K or L activity. Calcified Tissue International. 79: 245-54. PMID 17033726 DOI: 10.1007/S00223-005-0289-Z  0.055
2003 Halsall DJ, McFarlane I, Luan J, Cox TM, Wareham NJ. Typical type 2 diabetes mellitus and HFE gene mutations: a population-based case - control study. Human Molecular Genetics. 12: 1361-5. PMID 12783844 DOI: 10.1093/Hmg/Ddg149  0.053
2014 Cox TM, ffytche DH. Negative outcome Charles Bonnet syndrome. The British Journal of Ophthalmology. 98: 1236-9. PMID 24825847 DOI: 10.1136/Bjophthalmol-2014-304920  0.053
1994 Ali M, Sebastio G, Cox TM. Identification of a novel mutation (Leu256-->Pro) in the human aldolase B gene associated with hereditary fructose intolerance Human Molecular Genetics. 3: 684. PMID 8069328  0.053
2010 Roos JCP, Hyry HI, Cox TM. Orphan drug pricing may warrant a competition law investigation Bmj (Online). 341: 1084-1086. PMID 21081598 DOI: 10.1136/Bmj.C6471  0.052
1991 Whitcombe DM, Carter NP, Albertson DG, Smith SJ, Rhodes DA, Cox TM. Assignment of the human ferrochelatase gene (FECH) and a locus for protoporphyria to chromosome 18q22. Genomics. 11: 1152-4. PMID 1783383 DOI: 10.1016/0888-7543(91)90044-F  0.052
2014 Boyde A, Davis GR, Mills D, Zikmund T, Cox TM, Adams VL, Niker A, Wilson PJ, Dillon JP, Ranganath LR, Jeffery N, Jarvis JC, Gallagher JA. On fragmenting, densely mineralised acellular protrusions into articular cartilage and their possible role in osteoarthritis. Journal of Anatomy. 225: 436-46. PMID 25132002 DOI: 10.1111/Joa.12226  0.052
2010 Smith NJ, Marcus RE, Sahakian BJ, Kapur N, Cox TM. Haematopoietic stem cell transplantation does not retard disease progression in the psycho-cognitive variant of late-onset metachromatic leukodystrophy. Journal of Inherited Metabolic Disease. 33: S471-5. PMID 21080229 DOI: 10.1007/S10545-010-9240-1  0.052
2003 Hayman AR, Cox TM. Tartrate-resistant acid phosphatase knockout mice. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 18: 1905-7. PMID 14584904 DOI: 10.1359/Jbmr.2003.18.10.1905  0.051
2011 Pavlova EV, Deegan PB, Tindall J, McFarlane I, Mehta A, Hughes D, Wraith JE, Cox TM. Potential biomarkers of osteonecrosis in Gaucher disease Blood Cells, Molecules, and Diseases. 46: 27-33. PMID 21075651 DOI: 10.1016/J.Bcmd.2010.10.010  0.051
2002 Hollberg K, Hultenby K, Hayman AR, Cox TM, Andersson G. Osteoclasts from mice deficient in tartrate-resistant acid phosphatase have altered ruffled borders and disturbed intracellular vesicular transport Experimental Cell Research. 279: 227-238. PMID 12243748 DOI: 10.1006/Excr.2002.5612  0.051
1998 Kelly AL, Rhodes DA, Roland JM, Schofield P, Cox TM. Hereditary juvenile haemochromatosis: a genetically heterogeneous life-threatening iron-storage disease. Qjm : Monthly Journal of the Association of Physicians. 91: 607-18. PMID 10024915 DOI: 10.1093/Qjmed/91.9.607  0.051
1993 Cox TM, Wakeford R. The MB PhD programme. Training to be a clinician-scientist in the UK Journal of the Royal College of Physicians of London. 27: 147-150. PMID 8501673  0.051
2011 Mayr R, Griffiths WJH, Hermann M, McFarlane I, Halsall DJ, Finkenstedt A, Douds A, Davies SE, Janecke AR, Vogel W, Cox TM, Zoller H. Identification of mutations in SLC40A1 that affect ferroportin function and phenotype of human ferroportin iron overload Gastroenterology. 140: 2056-2063. PMID 21396368 DOI: 10.1053/J.Gastro.2011.02.064  0.051
2012 Cox TM, Brimicombe J, Wood DF, Peters DK. The Cambridge Bachelor of Medicine (MB)/Doctor of Philosophy (PhD): Graduate outcomes of the first MB/PhD programme in the UK Clinical Medicine, Journal of the Royal College of Physicians of London. 12: 530-534. PMID 23342406 DOI: 10.7861/Clinmedicine.12-6-530  0.05
1997 Smith SJ, Cox TM. Translational control of erythroid delta-aminolevulinate synthase in immature human erythroid cells by heme Cellular and Molecular Biology (Noisy-Le-Grand, France). 43: 103-114. PMID 9074795  0.05
2007 Kass ME, Crawford JM, Bennett B, Cox TM, Grimes MM, LiVolsi V, Fletcher CD, Wilkinson DS. Adequacy of pathology resident training for employment: a survey report from the Future of Pathology Task Group. Archives of Pathology & Laboratory Medicine. 131: 545-55. PMID 17425382 DOI: 10.1043/1543-2165(2007)131[545:AOPRTF]2.0.CO;2  0.05
2004 Lachmann RH, te Vruchte D, Lloyd-Evans E, Reinkensmeier G, Sillence DJ, Fernandez-Guillen L, Dwek RA, Butters TD, Cox TM, Platt FM. Treatment with miglustat reverses the lipid-trafficking defect in Niemann-Pick disease type C. Neurobiology of Disease. 16: 654-8. PMID 15262277 DOI: 10.1016/J.Nbd.2004.05.002  0.05
2001 Bune AJ, Hayman AR, Evans MJ, Cox TM. Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disordered macrophage inflammatory responses and reduced clearance of the pathogen, Staphylococcus aureus. Immunology. 102: 103-13. PMID 11168643 DOI: 10.1046/J.1365-2567.2001.01145.X  0.05
2012 Cachón-González MB, Wang SZ, McNair R, Bradley J, Lunn D, Ziegler R, Cheng SH, Cox TM. Gene transfer corrects acute GM2 gangliosidosis--potential therapeutic contribution of perivascular enzyme flow. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 1489-500. PMID 22453766 DOI: 10.1038/Mt.2012.44  0.049
2006 Cox TM, Beck M. Damage at the cellular and organ levels in LSDs: Possibility for prevention/reversibility with ERT Acta Paediatrica, International Journal of Paediatrics. 95: 75-76. PMID 16720470 DOI: 10.1080/08035320600619179  0.048
2015 Luzzatto L, Hollak CE, Cox TM, Schieppati A, Licht C, Kääriäinen H, Merlini G, Schaefer F, Simoens S, Pani L, Garattini S, Remuzzi G. Rare diseases and effective treatments: are we delivering? Lancet. 385: 750-2. PMID 25752159 DOI: 10.1016/S0140-6736(15)60297-5  0.047
2000 Griffiths WJH, Kelly AL, Smith SJ, Cox TM. Localization of iron transport and regulatory proteins in human cells Qjm - Monthly Journal of the Association of Physicians. 93: 575-587. PMID 10984552 DOI: 10.1093/Qjmed/93.9.575  0.045
2010 Hollak CEM, Aerts JMFG, Belmatoug N, Bembi B, Bodamer O, Cappellini D, Collin-Histed T, Cox TM, Deegan P, Giraldo P, Hughes D, Lukina E, Manuel J, Michelakakis H, Di Rocco M, et al. Guidelines for the restart of imiglucerase in patients with Gaucher disease: Recommendations from the European Working Group on Gaucher disease Blood Cells, Molecules, and Diseases. 44: 86-87. PMID 20022271 DOI: 10.1016/J.Bcmd.2009.12.002  0.044
1995 Sarkany RPE, Cox TM. Autosomal recessive erythropoietic protoporphyria: A syndrome of severe photosensitivity and liver failure Qjm. 88: 541-549. PMID 7648240 DOI: 10.1093/Oxfordjournals.Qjmed.A069099  0.043
2002 Cox TM, Halsall DJ. Hemochromatosis--neonatal and young subjects. Blood Cells, Molecules & Diseases. 29: 411-7. PMID 12547231 DOI: 10.1006/Bcmd.2002.0580  0.043
2015 Barnett-Vanes A, Ho G, Cox TM. Clinician-scientist MB/PhD training in the UK: a nationwide survey of medical school policy. Bmj Open. 5: e009852. PMID 26719322 DOI: 10.1136/Bmjopen-2015-009852  0.043
2007 Roberts HC, Knott L, Avery NC, Cox TM, Evans MJ, Hayman AR. Altered collagen in tartrate-resistant acid phosphatase (TRAP)-deficient mice: a role for TRAP in bone collagen metabolism. Calcified Tissue International. 80: 400-10. PMID 17551769 DOI: 10.1007/S00223-007-9032-2  0.043
2009 Cassata LC, Cox TM. Evaluation tool for clinical nursing textbooks: Bridging content analysis with evidence Journal of Nursing Education. 48: 301-309. PMID 19552316 DOI: 10.3928/01484834-20090515-02  0.042
2011 Sargeant TJ, Wang S, Bradley J, Smith NJ, Raha AA, McNair R, Ziegler RJ, Cheng SH, Cox TM, Cachón-González MB. Adeno-associated virus-mediated expression of β-hexosaminidase prevents neuronal loss in the Sandhoff mouse brain. Human Molecular Genetics. 20: 4371-80. PMID 21852247 DOI: 10.1093/Hmg/Ddr364  0.041
2012 Cox TM. Alkaptonuria: leading to the treasure in exceptions. Jimd Reports. 5: 49-57. PMID 23430917 DOI: 10.1007/8904_2011_93  0.041
2013 Hyry HI, Roos JC, Manuel J, Cox TM. The legal imperative for treating rare disorders Orphanet Journal of Rare Diseases. 8. PMID 24010951 DOI: 10.1186/1750-1172-8-135  0.041
1996 Ali M, James CL, Cox TM. A newly identified aldolase B splicing mutation (G→C, 5′ intron 5) in hereditary fructose intolerance from New Zealand Human Mutation. 7: 155-157. PMID 8829634 DOI: 10.1002/(Sici)1098-1004(1996)7:2<155::Aid-Humu11>3.0.Co;2-1  0.041
2015 Vitner EB, Vardi A, Cox TM, Futerman AH. Emerging therapeutic targets for Gaucher disease Expert Opinion On Therapeutic Targets. 19: 321-334. DOI: 10.1517/14728222.2014.981530  0.04
2010 Cox TM. Recommendations for treating patients with Gaucher disease with emerging enzyme products Blood Cells, Molecules, and Diseases. 44: 84-85. PMID 20022772 DOI: 10.1016/J.Bcmd.2009.12.001  0.04
2002 Cox TM. The genetic consequences of our sweet tooth. Nature Reviews. Genetics. 3: 481-7. PMID 12042775 DOI: 10.1038/Nrg815  0.04
1988 Shaunak S, Munro JM, Weinbren K, Walport MJ, Cox TM. Cyclophosphamide-induced liver necrosis: A possible interaction with azathioprine Qjm. 67: 309-317. PMID 3060893 DOI: 10.1093/oxfordjournals.qjmed.a068201  0.039
1996 Cox TM, Marth RB. Personal navigation Military Engineer. 27.  0.039
1989 Cross NCP, Cox TM. Molecular analysis of aldolase b genes in the diagnosis of hereditary fructose intolerance in the united kingdom Qjm. 73: 1015-1020. PMID 2623136 DOI: 10.1093/oxfordjournals.qjmed.a068388  0.039
1988 Gardner LC, Cox TM. Biosynthesis of heme in immature erythroid cells. The regulatory step for heme formation in the human erythron. The Journal of Biological Chemistry. 263: 6676-82. PMID 3360800  0.039
2013 Linthorst GE, Burlina AP, Cecchi F, Cox TM, Fletcher JM, Feldt-Rasmussen U, Giugliani R, Hollak CE, Houge G, Hughes D, Kantola I, Lachmann R, Lopez M, Ortiz A, Parini R, et al. Recommendations on reintroduction of agalsidase Beta for patients with fabry disease in europe, following a period of shortage. Jimd Reports. 8: 51-6. PMID 23430520 DOI: 10.1007/8904_2012_160  0.039
2007 Beck M, Cox TM, Gal A, Mehta AB. Sixth International Symposium on Lysosomal Storage Diseases Acta Paediatrica, International Journal of Paediatrics. 96: 1-2. DOI: 10.1111/J.1651-2227.2007.00195.X  0.039
1979 Cox TM, Fagan EA, Hillyard CJ. Role of calcitonin in diarrhoea associated with medullary carcinoma of the thyroid Gut. 20: 629-633. PMID 226460 DOI: 10.1136/gut.20.7.629  0.039
1994 Ali M, Sebastio G, Cox TM. Corrigendum: Identification of a novel mutation (Leu256 → Pro) in the human aldolase B gene associated with hereditary fructose intolerance (Human Molecular Genetics (1994) 3 (203-204)) Human Molecular Genetics. 3: 684.  0.039
1980 Cox TM, Peters TJ. Cellular mechanisms in the regulatijon of iron absorption by the human intestine: Studies in patients with iron deficiency before and after treatment British Journal of Haematology. 44: 75-86. PMID 7378295  0.038
1983 Cox TM, O'Donnell MW, Camilleri M, Burghes AH. Isolation and characterization of a mutant liver aldolase in adult hereditary fructose intolerance. Identification of the enzyme variant by radioassay in tissue biopsy specimens Journal of Clinical Investigation. 72: 201-213. PMID 6348085 DOI: 10.1172/JCI110958  0.037
1989 Whitaker KB, Cox TM, Moss DW. An immunoassay of human band 5 ('tartrate-resistant') acid phosphatase that involves the use of anti-porcine uteroferrin antibodies Clinical Chemistry. 35: 86-89. PMID 2910585  0.037
1994 Sarkany RPE, Alexander GJMA, Cox TM. Recessive inheritance of erythropoietic protoporphyria with liver failure The Lancet. 343: 1394-1396. PMID 7910885 DOI: 10.1016/S0140-6736(94)92525-9  0.036
1987 Echetebu ZO, Cox TM, Moss DW. Antibodies to porcine uteroferrin used in measurement of human tartrate-resistant acid phosphatase Clinical Chemistry. 33: 1832-1836. PMID 3117432  0.036
2009 Cox TM. Biomarkers in Lysosomal storage disorders with reference to Gaucher disease Clinical Therapeutics. 31: S183-S184. DOI: 10.1016/S0149-2918(09)00428-7  0.035
2006 Karabulut HG, Halsall D, Sayin BD, Tonyukuk V, Cox TM, Bökesoy I. Aldolase b mutations in Turkish families from Central Anatolia [1] Genetic Counseling. 17: 457-460. PMID 17375533  0.034
2016 Hyry HI, Cox TM, Roos JC. Saving the orphan drug legislations: misconceptions and clarifications. Expert Review of Pharmacoeconomics & Outcomes Research. PMID 26768506 DOI: 10.1586/14737167.2016.1141052  0.034
1990 Cross NCP, Stojanov LM, Cox TM. A new aldolase B variant, N334K, is a common cause of hereditary fructose intolerance in Yugoslavia Nucleic Acids Research. 18: 1925. PMID 2336380 DOI: 10.1093/nar/18.7.1925  0.034
1997 Johnson GV, Cox TM, Lockhart JP, Zinnerman MD, Miller ML, Powers RE. Transglutaminase activity is increased in Alzheimer's disease brain. Brain Research. 751: 323-9. PMID 9099822 DOI: 10.1016/S0006-8993(96)01431-X  0.033
1993 Mistry PK, Cox TM. The glucocerebrosidase locus in Gaucher's disease: Molecular analysis of a lysosomal enzyme Journal of Medical Genetics. 30: 889-894. PMID 8301642 DOI: 10.1136/jmg.30.11.889  0.033
1980 Cox TM, Peters TJ. In vitro studies of duodenal iron uptake in patients with primary and secondary iron storage disease Qjm. 49: 249-257. PMID 7465761 DOI: 10.1093/oxfordjournals.qjmed.a067620  0.033
1982 Cox TM, O'donnell MW. Studies on the control of iron uptake by rabbit small intestine British Journal of Nutrition. 47: 251-258. PMID 7066288 DOI: 10.1079/BJN19820033  0.032
1993 Cox TM. Iatrogenic deaths in hereditary fructose intolerance Archives of Disease in Childhood. 69: 413-415. PMID 8259868 DOI: 10.1136/Adc.69.4.413  0.032
2016 Marques AR, Mirzaian M, Akiyama H, Wisse P, Ferraz MJ, Gaspar P, Ghauharali-van der Vlugt K, Meijer R, Giraldo P, Alfonso P, Irún P, Dahl M, Karlsson S, Pavlova EV, Cox TM, et al. Glucosylated cholesterol in mammalian cells and tissues: formation and degradation by multiple cellular β-glucosidases. Journal of Lipid Research. PMID 26724485 DOI: 10.1194/Jlr.M064923  0.032
1997 Johnson GV, Seubert P, Cox TM, Motter R, Brown JP, Galasko D. The tau protein in human cerebrospinal fluid in Alzheimer's disease consists of proteolytically derived fragments. Journal of Neurochemistry. 68: 430-3. PMID 8978756 DOI: 10.1046/j.1471-4159.1997.68010430.x  0.031
2015 Cox TM. Innovative treatments for lysosomal diseases Best Practice and Research: Clinical Endocrinology and Metabolism. 29: 275-311. DOI: 10.1016/j.beem.2015.01.001  0.031
2008 Chen Y, Allegood J, Liu Y, Wang E, Cachón-González B, Cox TM, Merrill AH, Sullards MC. Imaging MALDI mass spectrometry using an oscillating capillary nebulizer matrix coating system and its application to analysis of lipids in brain from a mouse model of Tay-Sachs/Sandhoff disease Analytical Chemistry. 80: 2780-2788. PMID 18314967 DOI: 10.1021/Ac702350G  0.031
1993 Cox TM. Gaucher's disease: a brand leader The Lancet. 342: 694-695. PMID 8103817 DOI: 10.1016/0140-6736(93)91703-O  0.031
1999 Griffiths WJH, Kelly AL, Cox TM. Inherited disorders of iron storage and transport Molecular Medicine Today. 5: 431-435. PMID 10498911 DOI: 10.1016/S1357-4310(99)01541-5  0.031
2012 Cox TM. Current Treatments Lysosomal Storage Disorders: a Practical Guide. 151-165. DOI: 10.1002/9781118514672.ch20  0.03
2012 Pavlova EV, Deegan PB, Cox TM. Biomarkers for osteonecrosis in Gaucher disease Expert Opinion On Medical Diagnostics. 6: 1-13. DOI: 10.1517/17530059.2012.626402  0.03
1993 Cheever AW, Eltoum IA, Andrade ZA, Cox TM. Biology and pathology of Schistosoma mansoni and Schistosoma japonicum infections in several strains of nude mice American Journal of Tropical Medicine and Hygiene. 48: 496-503. PMID 8480857  0.03
2006 Esfandiari E, Bailey M, Stokes CR, Cox TM, Evans MJ, Hayman AR. TRACP Influences Th1 pathways by affecting dendritic cell function. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 21: 1367-76. PMID 16939395 DOI: 10.1359/Jbmr.060611  0.03
2005 Roos JC, Cox TM. Glycogen storage diseases and cardiomyopathy. The New England Journal of Medicine. 352: 2553; author reply 2. PMID 15958815 DOI: 10.1056/Nejm200506163522417  0.03
1981 Cox TM, O'Donnel MW, Voyles CR, Smadja C. Iron-binding glycoprotein receptors in human intestinal brush borders Gut. 22.  0.029
1980 Cox TM. Prevalence of the hemochromatosis gene New England Journal of Medicine. 302: 695-696. PMID 7354773  0.029
1979 Cox TM, Mazurier J, Spik G, Montreul J, Peters TJ. Iron binding proteins and influx of irom across the duodenal brush border. Evidence for specific lactotransferrin receptors in the human intestine Bba - General Subjects. 588: 120-128. PMID 227471 DOI: 10.1016/0304-4165(79)90377-5  0.029
2009 Jeyakumar M, Williams I, Smith DA, Cox TM, Platt FM. Critical role of iron in the pathogenesis of the murine gangliosidoses Neurobiology of Disease. 34: 406-416. PMID 19449457 DOI: 10.1016/J.Nbd.2009.01.015  0.029
1997 Allen MJ, Myer BJ, Khokher AM, Rushton N, Cox TM. Pro-inflammatory cytokines and the pathogenesis of Gaucher's disease: increased release of interleukin-6 and interleukin-10. Qjm : Monthly Journal of the Association of Physicians. 90: 19-25. PMID 9093585 DOI: 10.1093/Qjmed/90.1.19  0.029
2010 Chen Y, Liu Y, Allegood J, Wang E, Cachón-González B, Cox TM, Merrill AH, Sullards MC. Imaging MALDI mass spectrometry of sphingolipids using an oscillating capillary nebulizer matrix application system Methods in Molecular Biology. 656: 131-146. PMID 20680588 DOI: 10.1007/978-1-60761-746-4_7  0.028
1983 Cox TM, O'Donnell MW, Sochor M. Hereditary fructose intolerance: presence of a potent inhibitor of fructose 1-phosphate aldolase in the liver Biochemical Society Transactions. 11: 202-203.  0.028
2001 Griffiths WJH, Sly WS, Cox TM. Intestinal iron uptake determined by divalent metal transporter is enhanced in HFE-deficient mice with hemochromatosis Gastroenterology. 120: 1420-1429. PMID 11313312 DOI: 10.1053/Gast.2001.24050  0.027
2008 Keynes M, Cox TM. William Bateson, the rediscoverer of Mendel Journal of the Royal Society of Medicine. 101: 104. PMID 18344463 DOI: 10.1258/jrsm.2008.081011  0.027
1979 Cox TM, Peters TJ. The kinetics of iron uptake in vitro by human duodenal mucosa: Studies in normal subjects Journal of Physiology. 469-478. PMID 458682 DOI: 10.1113/jphysiol.1979.sp012747  0.026
1978 Cox TM, Peters TJ. UPTAKE OF IRON BY DUODENAL BIOPSY SPECIMENS FROM PATIENTS WITH IRON-DEFICIENCY ANÆMIA AND PRIMARY HÆMOCHROMATOSIS The Lancet. 311: 123-124. PMID 87554 DOI: 10.1016/S0140-6736(78)90420-8  0.026
2009 Cox TM. Hereditary Fructose Intolerance Genetic Diseases of the Kidney. 617-641. DOI: 10.1016/B978-0-12-449851-8.00036-X  0.025
1985 Cox TM, O'Donnell MW, Aisen P, London IM. Biosynthesis of the transferrin receptor in rabbit reticulocytes. The Journal of Clinical Investigation. 76: 2144-50. PMID 3001142 DOI: 10.1172/Jci112220  0.025
2013 Kovacs C, Curran M, Cox T. Where's That Dolphin? The Science Teacher. 80. DOI: 10.2505/4/tst13_080_09_24  0.025
1985 Cox TM, O'Donnell MW, Aisen P, London IM. Hemin inhibits internalization of transferrin by reticulocytes and promotes phosphorylation of the membrane transferrin receptor. Proceedings of the National Academy of Sciences of the United States of America. 82: 5170-4. PMID 2991909 DOI: 10.1073/Pnas.82.15.5170  0.024
2013 Cox TM. Competing for the treasure in exceptions American Journal of Hematology. 88: 163-165. PMID 23400870 DOI: 10.1002/Ajh.23399  0.024
1991 Gardner LC, Smith SJ, Cox TM. Biosynthesis of delta-aminolevulinic acid and the regulation of heme formation by immature erythroid cells in man. The Journal of Biological Chemistry. 266: 22010-8. PMID 1939222  0.024
1982 O'Donnell MW, Cox TM. Microvillar iron-binding glycoproteins isolated from the rabbit small intestine Biochemical Journal. 202: 107-115. PMID 6282268  0.024
1991 Cox TM. Fructose intolerance: diet and inheritance Proceedings of the Nutrition Society. 50: 305-309. PMID 1749797  0.023
1983 Cox TM. IRON ABSORPTION IN SMALL BOWEL The Lancet. 322: 214-215. PMID 6135042 DOI: 10.1016/S0140-6736(83)90188-5  0.023
1986 Warren JB, Rees HC, Cox TM. Remission of Crohn's disease with tuberculosis chemotherapy. The New England Journal of Medicine. 314: 182. PMID 3941699 DOI: 10.1056/NEJM198601163140314  0.022
2001 Jones SJ, Boyde A, Hayman AR, Cox TM. Bone structure in transgenic mice overexpressing tartrate-resistant acid phosphatase (AcP5, TRAP) Scanning. 23: 95-96.  0.022
1984 Anagnostides AA, Cox TM, Adrian TE, Christofides ND, Maton PN, Bloom SR, Chadwick VS. Pancreatic exocrine and endocrine responses in chronic pancreatitis American Journal of Gastroenterology. 79: 206-211. PMID 6367435  0.021
1990 Cox TM, Dollery CT, Bloom SR, Watts R, Wallis S, Winter R. An independent diagnosis: A treatable metabolic disorder is diagnosed by molecular analysis of human genes British Medical Journal. 300: 1512-1514. PMID 2372606  0.02
1977 Hopkins J, Cox TM, Peters TJ. Role of mitochondria in iron transport by guinea-pig small intestine Gut. 18.  0.02
1998 Cox TM, Norris PGN. The treatment of erythropoietic protoporphyria Micheline M. Matthews- Roth M.D. (multiple letters) Seminars in Liver Disease. 18: 425-426. PMID 9875559  0.02
1989 Cox TM, Lord DK. Hereditary haemochromatosis European Journal of Haematology. 42: 113-125. PMID 2645165 DOI: 10.1111/j.1600-0609.1989.tb01200.x  0.02
1977 Cox TM, Peters TJ. In vitro uptake of iron by human duodenal biopsies Gut. 18.  0.019
1986 Proby CM, Hackett D, Gupta S, Cox TM. Acute myopericarditis in influenza A infection Qjm. 60: 887-892. PMID 3628704 DOI: 10.1093/oxfordjournals.qjmed.a068046  0.018
1981 Cox TM, O'Donnell MW. Iron binding and the transport of iron across the rabbit intestinal brush border Biochemical Society Transactions. 9: 157-158. PMID 7215654  0.018
2008 Cox TM, Platt FM, Aerts JMFG. Medicinal use of Iminosugars Iminosugars: From Synthesis to Therapeutic Applications. 295-326. DOI: 10.1002/9780470517437.ch13  0.017
2007 Ross TP, Calhoun E, Cox T, Wenner C, Kono W, Pleasant M. The reliability and validity of qualitative scores for the Controlled Oral Word Association Test. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 22: 475-88. PMID 17317094 DOI: 10.1016/j.acn.2007.01.026  0.016
1992 Carthew P, Edwards RE, Smith AG, Cox TM. Excessive ferritin accumulation in fibroblast cells is associated with hepatic fibrosis due to iron overload in man Human and Experimental Toxicology. 11: 416-417.  0.015
1993 Whitcombe DM, Cox TM. Dinucleotide repeat polymorphism at the locus for human ferrochelatase (FECH) Human Molecular Genetics. 2: 826. PMID 8353511 DOI: 10.1093/Hmg/2.6.826  0.013
2015 Hyry HI, Roos JCP, Cox TM. Orphan drugs: Expensive yet necessary Qjm. 108: 269-272. DOI: 10.1093/qjmed/hcu240  0.012
1981 Cox TM, O'Donnell MW. Studies on the binding of iron by rabbit intestinal microvillus membranes Biochemical Journal. 194: 753-759. PMID 7306022  0.012
1988 de Franchis R, Cross NCP, Foulkes NS, Cox TM. A potent inhibitor of Taq polymerase copurifies with human genomic DNA Nucleic Acids Research. 16: 10355. PMID 3194201 DOI: 10.1093/nar/16.21.10355  0.011
1984 Cox TM, O'Donnell MW, Aisen P, London IM. Biosynthesis of transferrin receptors in reticulocytes Federation Proceedings. 43: no. 3651.  0.01
2016 Sale JE, Cox TM. Editorial. Expert Reviews in Molecular Medicine. 18: e10. PMID 27160347 DOI: 10.1017/erm.2016.10  0.01
2014 Presta M, Belleri M, Cox TM. The role of the endothelium in globoid-cell leukodystrophy: Unexpected revelations Future Neurology. 9: 127-130. DOI: 10.2217/fnl.13.75  0.01
2012 Cox TM. Protoporphyria The Porphyrin Handbook: Medical Aspects of Porphyrins. 14: 121-149. DOI: 10.1016/B978-0-08-092388-8.50012-1  0.01
2012 Winchester B, Cox TM. Other Lysosomal Disorders Lysosomal Storage Disorders: a Practical Guide. 142-149. DOI: 10.1002/9781118514672.ch19  0.01
2009 Roos JC, Cox TM. Giant osteoclast formation and long-term oral bisphosphonate therapy. The New England Journal of Medicine. 360: 1676-7; author reply. PMID 19373965  0.01
2008 Nash KL, Cox TM, Alexander GJM. Is cyclosporin the immunosuppressant of choice for liver transplantation for erythropoietic protoporphyria? [4] Transplant International. 21: 192-193. PMID 17944799 DOI: 10.1111/J.1432-2277.2007.00587.X  0.01
2006 Beck M, Cox TM, Mehta AB, Widmer U. Acta Paediatrica, International Journal of Paediatrics: Foreword Acta Paediatrica, International Journal of Paediatrics. 95: 5-6. DOI: 10.1080/08035320600619450  0.01
2003 Beck M, Cox TM, Ricci R. Acta Paediatrica: International Journal of Paediatrics - Foreword Acta Paediatrica, International Journal of Paediatrics, Supplement. 92: 1.  0.01
2003 Beutler E, Platt FM, Butters TD, Cox TM. Miglustat: A Viewpoint Drugs. 63: 2435-2436.  0.01
2002 Beck M, Cox TM, Vanier MT. Acta Pædiatrica: International Journal of pædiatrica: Foreword Acta Paediatrica, International Journal of Paediatrics, Supplement. 91: 1-2.  0.01
1999 Cox TM. The academic clinician Journal of the Royal College of Physicians of London. 33: 411-413. PMID 10624652  0.01
1999 Cox TM. Medical education: Catering for the carers as well as the innovators [4] Molecular Medicine Today. 5: 103-104. PMID 10203732 DOI: 10.1016/S1357-4310(99)01447-1  0.01
1996 Sarkany RPE, Cox TM. Liver failure in erythropoietic protoporphyria [3] Journal of the American Academy of Dermatology. 34: 540-541. PMID 8609281 DOI: 10.1016/S0190-9622(96)90473-9  0.01
1996 Ni J, Qiu Y, Cox TM, Jones CA, Berry C, Melon L, Bott S. Carbon dioxide chemistry: Characterization of the carbon dioxide reaction product of a dinuclear titanium complex Organometallics. 15: 4669-4671.  0.01
1995 Cheever AW, Finkelman FD, Cox TM. Anti-interleukin-4 treatment diminishes secretion of Th2 cytokines and inhibits hepatic fibrosis in murine schistosomiasis japonica Parasite Immunology. 17: 103-109. PMID 7761107  0.01
1993 Rosien U, Cox TM, Ali M, Dignass A, Daul A, Layer P, Hager W. [Acute hepatorenal failure in hereditary fructose intolerance]. Medizinische Klinik (Munich, Germany : 1983). 88: 553-4. PMID 8232096  0.01
1993 Cheever AW, Xu Y, Sher A, Finkelman FD, Cox TM, Macedonia JG. Schistosoma japonicum-infected mice show reduced hepatic fibrosis and eosinophilia and selective inhibition of interleukin-5 secretion by CD4+ cells after treatment with anti-interleukin-2 antibodies. Infection and Immunity. 61: 1288-92. PMID 8095922 DOI: 10.1128/Iai.61.4.1288-1292.1993  0.01
1991 Bevilacqua MA, Lord DK, Cross NCP, Whitaker KB, Moss DW, Cox TM. Regulation and expression of type V (tartrate-resistant) acid phosphatase in human mononuclear phagocytes Molecular Biology and Medicine. 8: 135-140. PMID 1943685  0.01
1990 Dokal IS, Cox TM, Galton DAG. Vitamin B-12 and folate deficiency presenting as leukaemia British Medical Journal. 300: 1263-1264. PMID 2354298  0.01
1990 Dokal IS, Cox TM, Galton DAG. Vitamin B-12 and folate deficiency presenting as leukaemia (I: Reply) British Medical Journal. 301: 42.  0.01
1987 Nunn AV, Gardner LC, Cox TM. Molecular forms of porphobilinogen deaminase in acute intermittent porphyria. A study by Western immunoblotting. The Quarterly Journal of Medicine. 64: 589-99. PMID 3671663  0.01
Hide low-probability matches.